EXCITATION of Golgi tendon organs by direct electrical stimulation of human muscles produces an autogenous inhibition 1,2 of 80–100 msec. In patients suffering from Parkinson's diseasethis ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

MSA is divided into MSA-C (cerebellar type) which has more symptoms of ataxia (incoordination) and MSA-P (parkinsonian type) which has more parkinsonian symptoms but is relatively unresponsive to the ...

Oct. 4, 2024 — A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function ...

About bioMUSE Biomarkers of progression in Multiple System Atrophy (bioMUSE) is a natural history study that aims to track the progression of individuals with MSA, a parkinsonian disorder without ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

The PD pipeline demonstrates a significant research effort to address these needs within the 7MM. A total of 18% of the ...

A million Americans have Parkinson’s disease, and that number is expected to increase to 1.2 million by 2030. Most of those afflicted are between 75 and 85, but 4% are under 50. The cause is still ...

Access to the abstract and full publication are available here.

Data presented at Psych Congress 2024 showed improvements in social functioning and quality of life over an eight-week ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...